| Cat. No. |
Size |
Price |
Figures |
|---|
RP11731-1 mg
| 1 mg | $ 40.00 | HPLC: 20060721145623 (PDF)
MS: 20060721145602 (PDF)
MSDS: 20080213021854 (PDF)
References:
- Lee AS, et al. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. J. Immunol. Methods. Dec 2005; 307(1-2): 62-72.
- Reinhold AC and Ekstrom J. Expressions of CCAAT-enhancer-binding proteins and c-Myc in the parotid gland of the rat: in vivo effects of isoprenaline, bethanechol, vasoactive intestinal peptide and food intake. Arch. Oral Biol. May 2004; 49(5): 345-354.
- Jain AA and Rajeswari MR. Binding studies on peptide-oligonucleotide complex: intercalation of tryptophan in GC-rich region of c-myc gene. Biochim. Biophys. Acta. Jul 2003; 1622(2): 73-81.
|
|---|
RP11731-5 mg
| 5 mg | $ 76.00 |
|---|
| Full Name | |
Sequence
(one-letter code) |
EQKLISEEDL |
Sequence
(three-letter code) | {GLU}{GLN}{LYS}{LEU}{ILE}{SER}{GLU}{GLU}{ASP}{LEU} |
|---|
| Description | c-Myc Peptide is a useful for displacement of c-Myc-tagged fusion proteins bound to anti-c-Myc antibodies in immunoassays. The successful inhibition of antibody binding by c-Myc peptide demonstrates binding is specific. c-Myc Peptide participates in regulation of growth-related gene transcription. |
|---|
| Solubility | Soluble in PBS, pH 7.0. The optimal working dilution should be determined for each specific assay condition. |
|---|
| Formula | C51H86N12O21 |
|---|
| M.W. | 1203.3 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. Keep tightly closed. |
| Notes | Amino acid sequence of c-Myc Peptide is corresponds to amino acids 410-419 of the C-terminal of human c-Myc. This peptide is sold for laboratory research use only, not for human or in-vivo use. This peptide may not be resold or modified for resale without prior written approval. |
|---|
